C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2700219
The use of the single nucleotide polymorphism (SNP) of the CLEC1B gene for the identification of cardiovascular and/or thrombotic disorders or of an increased risk for developing cardiovascular and/or thrombotic disorders in a biological sample taken from an individual to be examined; the use of CLEC1B for identifying substances active in preventing and/or treating cardio-vascular and/or thrombotic disorders and methods for doing so.
La présente invention concerne l'utilisation du polymorphisme nucléotidique simple (SNP de l'anglais single nucleotide polymorphism) du gène CLEC 1 B pour l'identification de troubles cardiovasculaires et/ou thrombotiques ou d'un risque accru de développer des troubles cardiovasculaires et/ou thrombotiques dans un échantillon biologique prélevé sur un individu à examiner. L'invention concerne également l'utilisation de CLEC1B pour identifier des substances actives dans la prévention et/ou le traitement de troubles cardiovasculaires et/ou thrombotiques ainsi que des procédés permettant cette identification.
Herrmann Matthias
Kozian Detlef
Wonerow Peter
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis
LandOfFree
Use of clec1b for the determination of cardiovascular and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of clec1b for the determination of cardiovascular and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of clec1b for the determination of cardiovascular and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1423410